Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	1198
Mentorship in the lives of scholars	1035
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	661
The GLP-1 receptor agonist revolution comes to nephrology	610
Engineered CAR macrophages target kidney inflammation	584
CD93 and endothelial cells as therapeutic targets in podocytopathies	486
The changing landscape of kidney health and disease in Africa	431
Disaster preparedness for patients with kidney disease	373
Vaccination in patients with kidney failure: lessons from COVID-19	325
Making advance care planning easier for adults with kidney disease and their clinicians	305
The versatile roles of long non-coding RNAs in kidney disease	291
Uropathogen and host responses in pyelonephritis	276
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	255
Author Correction: Salt and chronic kidney disease	243
Role of the gut microbiota in the pathogenesis of IgA nephropathy	237
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	228
Kidney health within the broader non-communicable disease agenda	227
Designing acute kidney injury clinical trials	217
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	197
Treatment of chronic kidney disease in older populations	183
Genetic determinants of urine and plasma metabolite levels	180
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	174
Beyond state borders: transforming dialysis care for undocumented immigrants	170
The continued odyssey to unravel the secrets of kidney inflammation	158
Consideration of sex differences is necessary to achieve health equity	154

Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis	153
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	146
Roles of sensory receptors in non-sensory organs: the kidney and beyond	146
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	145
Nephrology care for incarcerated people: a call to action	126
Complosome — the intracellular complement system	119
Phosphate sensing via PTC glycolysis	118
Informing clinical decision making during a pandemic — a call for better preparedness	117
Increasing diversity and inclusion in nephrology clinical trials	112
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	111
The effects of sex hormone therapy on kidney function	108
Clonal haematopoiesis and AKI	106
20 years of Nature Reviews Nephrology	103
Mutational signatures of ccRCC vary between geographical regions	100
Reducing preventable acute kidney injury in a hospital setting	100
The impact of social determinants of health on acute kidney injury	99
Menopause and chronic kidney disease	97
Aquaporin water channels: roles beyond renal water handling	96
Design of a renal-sparing antifungal	93
The roles of hyaluronan in kidney development, physiology and disease	93
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	91
Tertiary lymphoid organs contribute to kidney allograft rejection	90
Treatment of SLE with anti-CD19 CAR-T cells	88
Environmental stewardship and health systems: Indigenous-centred reflections	84
Identification of erythropoietin-producing cells	80
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	79
Heat and health inequity: acting on determinants of health to promote heat justice	78
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	77
From fat to filter: the effect of adipose tissue-derived signals on kidney function	77
Long-term health outcomes associated with hydration status	76
Neutrophils and NETs in kidney disease	76
The role of complement in kidney disease	75
Pathological mechanisms of kidney disease in ageing	74
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	72
The evolving landscape of immune-mediated glomerular diseases	70
A golden year of innovative kidney disease therapeutics	69
Reaping the rewards of mechanistic discovery in glomerular disease	67
MSC therapy for diabetic kidney disease and nephrotic syndrome	65
A label-free optical analysis for molecular nephrology	64
Atmospheric stressors and kidney diseases	62
HNF1B as a central gatekeeper of tubular homeostasis	62
A pathway of osmotic stress-induced necroptosis	60
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	59
Combination therapy for kidney disease in people with diabetes mellitus	59
Network medicine: an approach to complex kidney disease phenotypes	59
Ketogenic diet benefits in critically ill patients with sepsis	57
Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury	57
PDGFRβ CAR T cells improve fibrosis in kidney disease models	57
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	55
The cilia mechanosensation debate gets (bio)physical	55

Consequence of microvascular inflammation in transplantation	54
Community power building to reduce inequities in access to health care	53
Consequences of famine and malnourishment on kidney health	52
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	51
Long COVID and the kidney	50
Quality-oriented diet therapy for chronic kidney disease	49
Mechanism of B cell survival in lupus nephritis	48
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	48
Gene therapy in a model of nephrotic syndrome	46
The kidney is a novel target of metformin	46
Mannose as a driver of γδ T cell kidney infiltration	46
Targeting IL-1Ra to attenuate fungal infection	45
Generation of self-assembling kidney progenitor assembloids	45
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	45
Multifaceted innovations needed to advance transplant nephrology	45
Wearable biosensor can detect impaired kidney drug clearance	43
A guide to gene–disease relationships in nephrology	42
Steps forward in the treatment of IgA nephropathy	42
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	40
Born too soon: lifelong kidney risks and the importance of early intervention	40
Anti-neutrophil cytoplasmic antibody-associated vasculitis: biological insights and biomarker-guided disease management	40
Metabolic alterations in hereditary and sporadic renal cell carcinoma	39
Chronic cardiovascular–kidney disorder: a new conceptual framework	38
Role of necroptosis in kidney health and disease	36
Fasting induces structural and functional changes in the peritoneal membrane	36
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	36
Epithelial cell states associated with kidney and allograft injury	36
The genetics of hypertension	36
Derivation of collecting duct organoids	35
Insights into the impact of pregnancy on kidney disease	35
Strategies to achieve gender equity in nephrology	35
The increasing burden of mild and moderate anaemia in CKD	34
From big data to smart decisions: artificial intelligence in kidney risk assessment	34
Leveraging data as a patient–scientist: frustrations and opportunities	34
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects	34
Author Correction: Therapeutic advances in COVID-19	33
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	31
Green nephrology: from evidence to action	31
A guide to uraemic toxicity	30
The impact of intrauterine growth restriction and prematurity on nephron endowment	30
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	29
Acute kidney injury in patients with burns	28
Renal nerves in physiology, pathophysiology and interoception	28
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	27
The immunology of sepsis: translating new insights into clinical practice	27
Fibroblast activation and heterogeneity in fibrotic disease	27
CD38 — a new target in renal immune disease	25
Switching off SOX9 for epithelial recovery after AKI	25
When access outpaces ethics: reflections on dialysis expansion and health system integrity	24
Collagen formation, function and role in kidney disease	24
Impact of persistent conflict and destabilizing events on dialysis care	24
Hope for resistant hypertension through BrigHTN and PRECISION	24
Crosstalk between glomeruli and tubules	23
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	23
The impact of population ageing on the burden of chronic kidney disease	23
Digital determinants of health: opportunities and risks amidst health inequities	23
Nephrology and women’s health post-Roe v. Wade: we must do better	22
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	22
Bridging the gap of referral to nephrology care	21
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	21
Deep learning applications in digital pathology	20
Indigenous kidney health outcomes will not improve without multilevel interventions	20
Kidney transplants: from antigen recognition to targeted therapy	20
A novel gene therapy approach for nephropathic cystinosis	19
A spatial atlas identifies tertiary lymphoid tissue-like structures in DKD	18
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	18
Podocyte-targeted therapies — progress and future directions	17
The endothelium response to kidney injury	16
A year of disruption and progress in kidney health policy	16
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	15
Pathogenic cellular and molecular mediators in lupus nephritis	15
Lived experience and empathy: lessons learned as a nephrologist with kidney disease	14
Cellular senescence: the good, the bad and the unknown	14
Increased PD1 signalling in kidney ageing	14
Use of kidneys from SARS-CoV-2 infected donors	14
New and emerging therapies for diabetic kidney disease	13
Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	13
Beyond consent: community engagement, benefit sharing and reciprocity in kidney genomics research	12
New evidence of the impact of mitochondria on kidney health and disease	12
TRPM channels in health and disease	12

Trained immunity: from kidney failure to organ transplantation	12
Insights into glomerular function and disease pathogenesis	12
Progress towards solving the donor organ shortage	11
Incorporating dementia screening in the care of patients with kidney disease	11
Gasdermins and pyroptosis in the kidney	11
Vascular damage in systemic lupus erythematosus	11
Advances and challenges in kidney fibrosis therapeutics	11
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	10
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	10
Pharmacogenomics in the clinic	10
Cystatin C and the misdiagnosis of CKD in older adults	10
Thiazides in kidney transplant recipients: skin in the game	10
Kidney health outcomes of hypertensive disorders of pregnancy	9
Advances in risk prediction and treatment strategies for CKM syndrome	9
Cell and gene therapy for kidney disease	9
Diuretics in patients with chronic kidney disease	9
Clonal haematopoiesis, ageing and kidney disease	9
ECM remodelling by ADAMTS12 in fibrosis	8
Youth-onset type 2 diabetes mellitus: an urgent challenge	8
Patient involvement in nephrology research	8
The genetics and pathogenesis of CAKUT	8
Electronic patient-reported outcomes in chronic kidney disease	8
Metabolic determinants of autoimmune kidney diseases	8
The social needs of patients with kidney failure	8
Advances in CRISPR therapeutics	8
Inflammation and gut dysbiosis as drivers of CKD–MBD	8
Advancing gender equity to improve kidney care for women: a patient perspective	8
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	8
The role of lysosomes in metabolic and autoimmune diseases	7
Disasters and kidney care: pitfalls and solutions	7
Diagnosis of cardiovascular disease in patients with chronic kidney disease	7
A guide to studying 3D genome structure and dynamics in the kidney	7
The slit diaphragm has a conserved fishnet architecture	7
Chronic kidney disease and the global public health agenda: an international consensus	7
Long-term lessons from EMPA-KIDNEY	7
The pathogenesis of pre-eclampsia in kidney donors	7
The catastrophic costs of chronic kidney disease	7
Avenciguat reduces albuminuria in patients with chronic kidney disease	7
Remodelling by macula densa cells	7
Progress in xenotransplantation: overcoming immune barriers	7
The intelligent podocyte: sensing and responding to a complex microenvironment	7
Selective autophagy in kidney health and disease	7
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	7
Graph neural networks for computational nephrology	6
Intersectionality as a lens for achieving kidney health justice	6
‘Missing’ disease-causing variants in Alport syndrome	6
Including sexual orientation and gender identity data to advance nephrology care	6
Paths to organ damage and risk factors in AKI	6
Amino acid metabolism in kidney health and disease	6
Drug repurposing for glomerular diseases: an underutilized resource	6
Inequities in kidney health and kidney care	6
New insights into kidney crosstalk with distant organs	6
From resolution to reality: advancing point-of-care diagnostics for kidney disease in low-resource settings	5
Cell–cell crosstalk in kidney health and disease	5
Post-translational modifications in kidney diseases and associated cardiovascular risk	5
Iron deficiency of kidney macrophages in CKD	5
Interactive exploration of multimodal spatial data with FUSION	5
Sexual orientation and gender identity in organ and tissue donation and transplantation	5
The roles of tertiary lymphoid structures in chronic diseases	5
Removal of small, asymptomatic kidney stones	5
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	5
A polygenic score predicts CKD across ancestries	5
The kidney stroma in development and disease	5
Sex differences in kidney metabolism and DKD	5
Targeting iron uptake to correct T cell dysfunction	5
Improving nephrology care for people with cognitive impairments and their caregivers	5
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	4
Propagation of acute kidney injury	4
Collagen IV in Gould syndrome and Alport syndrome	4
NCKs are essential to podocyte–GBM interactions	4
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease	4
Macrophages clean out the tubules	4
Kidney benefits of SLGT2 inhibitors: evidence from clinical trials	4
AngII autoantibodies after SARS-CoV-2 infection	4
Overcoming barriers to deliver high quality kidney care	4
The importance of sex and gender in basic and clinical research	4
Bridging structure and function: artificial intelligence-based modelling of kidney proteins	4
Long COVID: long-term health outcomes and implications for policy and research	4
Improving outcomes in kidney transplantation through advances in donor organ perfusion	4
Leveraging lysine metabolism for renoprotection	4
Protein handling in kidney tubules	4
Harnessing plant thylakoids to restore cellular function in AKI	4
Optimal patient care in advanced chronic kidney disease progressing to kidney failure	4
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’	4
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	3
Expanding the global nephrology workforce	3
Author Correction: The immunoregulatory roles of non-haematopoietic cells in the kidney	3
Therapeutic and mechanistic insights on mitochondrial transplantation in kidney disease	3
Thymic health and implications for chronic kidney disease	3
The global landscape of kidney registries: immense challenges and unique opportunities	3
VHL loss attracts immune cells to tumours	3
Chronic kidney disease screening in LMICs: benefits and challenges	3
Pathogenesis of autoimmune disease	3
Fiji’s rising tide: the growing burden of diabetic kidney disease on emerging nephrology services	3
Artificial intelligence approaches to enable early detection of CKD	3